Word

Status

Registered

Status Code

700

Status Date

Tuesday, September 15, 2020

Serial Number

88513447

Registration Number

6154613

Registration Date

Tuesday, September 15, 2020

Mark Type

2000

Filing Date

Sunday, July 14, 2019

Published for Opposition

Tuesday, December 24, 2019

Trademark Owner History

CantonBio AG - Original Registrant

Classifications

1 Proteins for use in the manufacture of food supplements; proteins for the food industry; protein for use in the manufacture of cosmetics; protein in raw material form for scientific and medical research; protein for industrial use; animal albumen for use in the manufacture of skin care product; animal albumen as a raw material for industrial use; diagnostic preparations other than for medical or veterinary purposes; biological preparations for use in industry and science; biological preparation for use in cell cultures other than for medical or veterinary use; cultures of microorganisms, other than for medical and veterinary use; chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; biological tissue cultures, other than for medical or veterinary purposes; biochemical catalysts; stem cells, other than for medical or veterinary purposes

5 Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-inflammatories, anti-virals, anti-infectives, immunosuppressants and pharmaceutical antibodies; pharmaceuticals, namely, preparations for antibody and antibody-derivative development; pharmaceuticals, namely, antibodies and proteins for the treatment of oncological and autoimmune diseases and disorders; cytokine preparations and antibodies in the nature of pharmaceutical preparations for the treatment of oncological and autoimmune diseases and disorders; pharmaceutical preparations, namely, immuno- therapeutics and cytokines for the treatment of oncological and autoimmune diseases and disorders; diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; medicines for the treatment of gastrointestinal diseases, for human purposes; pharmaceutical products for the prevention and treatment of cancer, for human purposes; tumor suppressing agents, for human purpose; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for peripheral nervous system; vaccines; diagnostic preparations for medical purposes; chemical preparations for medical purposes, namely, for treating cancer; nutritional supplements; biocides; surgical glues

42 Biological research; medical and scientific research, namely, conducting clinical trials for others; research and development services in the field of antibodies; biotechnology research; testing of pharmaceuticals; analysis of the mode of action of chemical combinations on animals; bacteriological research; scientific laboratory services; scientific research; biomedical research services

Color is not claimed as a feature of the mark.
The mark consists of two crossed and surrounded vertical bars, forming a chain with two opposite short lines in the middle oval.

Trademark Events

Sep 15, 2020

Registered-Principal Register

Aug 14, 2020

Notice Of Acceptance Of Statement Of Use E-Mailed

Aug 13, 2020

Allowed Principal Register - Sou Accepted

Jul 24, 2020

Statement Of Use Processing Complete

Jul 5, 2020

Use Amendment Filed

Jul 24, 2020

Case Assigned To Intent To Use Paralegal

Jul 5, 2020

Teas Statement Of Use Received

Feb 18, 2020

Noa E-Mailed - Sou Required From Applicant

Dec 24, 2019

Official Gazette Publication Confirmation E-Mailed

Dec 24, 2019

Published For Opposition

Dec 4, 2019

Notification Of Notice Of Publication E-Mailed

Nov 20, 2019

Assigned To Lie

Nov 16, 2019

Approved For Pub - Principal Register

Nov 1, 2019

Teas/Email Correspondence Entered

Oct 31, 2019

Correspondence Received In Law Office

Oct 31, 2019

Teas Response To Office Action Received

Sep 30, 2019

Notification Of Non-Final Action E-Mailed

Sep 30, 2019

Non-Final Action E-Mailed

Sep 30, 2019

Non-Final Action Written

Sep 30, 2019

Assigned To Examiner

Jul 20, 2019

Notice Of Design Search Code E-Mailed

Jul 19, 2019

New Application Office Supplied Data Entered In Tram

Jul 17, 2019

New Application Entered In Tram